Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715520 · ClinicalTrials.gov registry record · NA
Neurobiological Principles Applied to the Rehabilitation of Stroke Patients
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00715520: Completed NA study, sponsored by Emory University.
NCT00715520 is a NA study that has completed, run by Emory University. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00715520, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study team may be able to provide information that improves rehabilitative treatment and helps to improve recovery after stroke.
Primary Outcome
Motor evoked potential (MEP) amplitudes were measured prior to treatment (baseline), immediately after the treatment (post-training 1), 30 minutes after the treatment (post-training 2), and 60 minutes after the treatment (post-training 3).The MEP is elicited by transcranial magnetic stimulation (TMS) at increased intensity. Its amplitude is measured from peak to peak and expressed in millivolts (mV). Measured MEP amplitudes were plotted against the intensity to create a stimulus response curve (
Interventions
- DRUG Placebo
- DRUG Methylphenidate
- OTHER Transcranial Magnetic Stimulation (TMS)
- DRUG Amphetamine Sulfate
- DRUG Carbidopa-Levodopa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2007-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT00715520 record still lists
NCT00715520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00715520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00715520 about?
NCT00715520 is a clinical study titled "Neurobiological Principles Applied to the Rehabilitation of Stroke Patients". The purpose of this study is to use (Transcranial Magnetic Stimulation) TMS or drugs to improve learning of movement skills and the adaptation processes in patients after stroke. Once investigators have determined the improving effect of TMS and the drugs on learning of movement skills, the study te...
What is the current status of trial NCT00715520?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2007-04. Estimated completion is 2016-09.
What interventions are being tested in trial NCT00715520?
The interventions under investigation include: Placebo (DRUG), Methylphenidate (DRUG), Transcranial Magnetic Stimulation (TMS) (OTHER), Amphetamine Sulfate (DRUG), Carbidopa-Levodopa (DRUG).
Who is sponsoring clinical trial NCT00715520?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00715520's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia